Catenin beta-1

Error creating thumbnail:

Error creating thumbnail:

Catenin beta-1 (also known as β-catenin) is a dual function protein, involved in regulation and coordination of cell–cell adhesion and gene transcription. It is encoded by the CTNNB1 gene in humans.

Structure

Catenin beta-1 is a 781 amino acid protein that contains several important domains, including the armadillo repeat domain, which is crucial for its interaction with other proteins. The protein is highly conserved across species, indicating its essential role in cellular functions.

Function

Catenin beta-1 plays a critical role in the Wnt signaling pathway, which is important for embryonic development, cell proliferation, and cell differentiation. In the absence of Wnt signals, β-catenin is constantly degraded by the proteasome. However, when Wnt signaling is activated, β-catenin accumulates in the cytoplasm and translocates to the nucleus, where it interacts with TCF/LEF transcription factors to activate the transcription of Wnt target genes.

Additionally, β-catenin is a key component of the cadherin protein complex, which mediates cell–cell adhesion. It binds to the intracellular domain of cadherins and links them to the actin cytoskeleton through α-catenin, thus playing a crucial role in maintaining the structural integrity of tissues.

Clinical Significance

Mutations in the CTNNB1 gene or dysregulation of β-catenin are associated with various types of cancer, including colorectal cancer, hepatocellular carcinoma, and melanoma. Aberrant activation of β-catenin can lead to uncontrolled cell proliferation and tumor development.

Interactions

Catenin beta-1 interacts with several proteins, including:

• E-cadherin
• APC
• Axin
• GSK-3β
• TCF/LEF transcription factors

These interactions are crucial for its role in both cell adhesion and Wnt signaling.

Research

Ongoing research is focused on understanding the precise mechanisms by which β-catenin regulates gene expression and cell adhesion, as well as its role in cancer and other diseases. Targeting β-catenin signaling pathways is considered a potential therapeutic strategy for treating cancers with aberrant Wnt signaling.

See Also

• Wnt signaling pathway
• Cadherin
• CTNNB1
• Cell adhesion
• Gene transcription